"MFN" の関連情報検索結果
The Great Healthcare Plan, MFN drug prices and the political implications of the end of ACA enhan...

The Great Healthcare Plan, MFN drug prices and the political implications of the end of ACA enhanced subsidies: Here are 7 takeaways from the MHE-AJMC webinar Managed Healthcare Executive
President Trump Announces Section 232 Tariffs on Pharmaceuticals and Active Pharmaceutical Ingred...

President Trump Announces Section 232 Tariffs on Pharmaceuticals and Active Pharmaceutical Ingredients thompsonhinesmartrade.com
Impact of U.S. Administration Pharmaceutical Policies: MFN Pricing and Tariff Exemptions Reshapin...

Trump eyes 100% tariff rate for companies that have not struck MFN deals: Bloomberg - Fierce Pharma

Trump eyes 100% tariff rate for companies that have not struck MFN deals: Bloomberg Fierce Pharma
Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says - CNBC

Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says CNBC
Policymakers shouldn’t double down on the IRA’s flaws with MFN - PhRMA

Policymakers shouldn’t double down on the IRA’s flaws with MFN PhRMA
US starts engaging drugmakers on putting Trump's MFN pricing into law - Reuters

US starts engaging drugmakers on putting Trump's MFN pricing into law Reuters
Annual and Sustainability Report 2025 - TradingView

Annual and Sustainability Report 2025 TradingView
The Most Favored Nation Policy: early insights into Europe’s response - Pharmaceutical Technology

The Most Favored Nation Policy: early insights into Europe’s response Pharmaceutical Technology
The potential loophole in Trump’s plan to get other countries to pay more for drugs - statnews.com

The potential loophole in Trump’s plan to get other countries to pay more for drugs statnews.com
Thus Far, Most Favored Nation Drug Prices Have Had Little Impact On Consumers - Forbes

Thus Far, Most Favored Nation Drug Prices Have Had Little Impact On Consumers Forbes
Editorial: Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling - BioSpace

Editorial: Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling BioSpace
More Than Just Pricing: MFN’s Impact on Pharma: Q&A with Lindsay Bealor Greenleaf - Pharmaceutica...

More Than Just Pricing: MFN’s Impact on Pharma: Q&A with Lindsay Bealor Greenleaf Pharmaceutical Executive
Astorg’s Nicolas Marien eyes opportunities in ingredients after Solabia triple add-on; Impact fro...

Gabather comments on the new patent application - TradingView

Gabather comments on the new patent application TradingView
MFN drug pricing risks reviving a harmful metric the U.S. rejected - PhRMA

MFN drug pricing risks reviving a harmful metric the U.S. rejected PhRMA
What Potential Fallout Will MFN Policies Have? - Pharmaceutical Executive

What Potential Fallout Will MFN Policies Have? Pharmaceutical Executive
Arion Bank: Reduction of share capital - TradingView

Arion Bank: Reduction of share capital TradingView
HEXPOL's Annual Report For 2025 Published - TradingView

HEXPOL's Annual Report For 2025 Published TradingView
Norion Bank publishes Annual Report for 2025 - TradingView

Norion Bank publishes Annual Report for 2025 TradingView
Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow - BioSpace

Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow BioSpace
How Will MFN’s Effects on Medicare Impact Innovation? - Pharmaceutical Executive

How Will MFN’s Effects on Medicare Impact Innovation? Pharmaceutical Executive
President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing - KFF

President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing KFF
How Does MFN Pricing Work Within TrumpRx? - Pharmaceutical Executive

How Does MFN Pricing Work Within TrumpRx? Pharmaceutical Executive
Trump may impose tariffs on drugmakers who haven't signed MFN deals - reports - MSN

Trump may impose tariffs on drugmakers who haven't signed MFN deals - reports MSN
Trump Administration Pursues MFN Pricing for Prescription Drugs - Crowell & Moring LLP

Trump Administration Pursues MFN Pricing for Prescription Drugs Crowell & Moring LLP
Is this farewell to MFN, the non-discrimination principle of the world trading system? - Peterson...

Is this farewell to MFN, the non-discrimination principle of the world trading system? Peterson Institute for International Economics
Prying open Pandora's box by scrapping MFN - Peterson Institute for International Economics

Prying open Pandora's box by scrapping MFN Peterson Institute for International Economics
Congress Seeks Answers on Most-Favored-Nation Drug Pricing Agreements and Their Impact on Medicai...

Congress Seeks Answers on Most-Favored-Nation Drug Pricing Agreements and Their Impact on Medicaid JD Supra
White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool reception - stat...

White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool reception statnews.com
CMS puts patients and innovation at risk with MFN - PhRMA

Sweden Initiates Drug Pricing Review in Response to MFN Policy - NAVLIN DAILY

Sweden Initiates Drug Pricing Review in Response to MFN Policy NAVLIN DAILY
Drug Policy Shift: MFN's Impact on Providers - Pharmaceutical Executive

Drug Policy Shift: MFN's Impact on Providers Pharmaceutical Executive
Trump’s Medicare director seeks to rein in expectations for TrumpRx - statnews.com

Trump’s Medicare director seeks to rein in expectations for TrumpRx statnews.com
White House Has Reportedly Begun Circulating Legislative Text to Codify MFN Deals - NAVLIN DAILY

White House Has Reportedly Begun Circulating Legislative Text to Codify MFN Deals NAVLIN DAILY
Most Favored Nation Drug Pricing and Manufacturer Agreements - Jones Day

Most Favored Nation Drug Pricing and Manufacturer Agreements Jones Day
REC SILICON ASA - NOTIFICATION OF MAJOR SHAREHOLDING - TradingView

REC SILICON ASA - NOTIFICATION OF MAJOR SHAREHOLDING TradingView
Trump most-favored nation drug pricing deals end after three years for some companies - statnews.com

Trump most-favored nation drug pricing deals end after three years for some companies statnews.com
Can Trump win over critics with MFN drug pricing plan? Former Biden advisor weighs in - Fierce Ph...

Can Trump win over critics with MFN drug pricing plan? Former Biden advisor weighs in Fierce Pharma
Say "NO" to Importing Foreign, Socialist Drug Price Controls - Americans for Tax Reform

Say "NO" to Importing Foreign, Socialist Drug Price Controls Americans for Tax Reform
CMS Issues Proposed Rules to Impose International MFN Drug Pricing for Portion of Medicare Part B...

U.S. Chamber Urges CMS to Drop Arbitrary MFN Pricing Models - IPWatchdog.com

U.S. Chamber Urges CMS to Drop Arbitrary MFN Pricing Models IPWatchdog.com
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026 - BioSpace

Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026 BioSpace
Advocacy group files FOIA lawsuit to gain further clarity on Trump administration's MFN pricing d...

Advocacy group files FOIA lawsuit to gain further clarity on Trump administration's MFN pricing deals Fierce Pharma
AbbVie inks MFN drug pricing deal, pledges $100bn to US R&D - Pharmaceutical Technology

AbbVie inks MFN drug pricing deal, pledges $100bn to US R&D Pharmaceutical Technology
Senator blasts GSK inhaler practices, calls for reform - statnews.com

Senator blasts GSK inhaler practices, calls for reform statnews.com
MFN undermines U.S. biopharmaceutical innovation - PhRMA

Worried Trump's MFN push will 'destroy biotech innovation,' midsize companies form coalition to f...

Worried Trump's MFN push will 'destroy biotech innovation,' midsize companies form coalition to fight back Fierce Biotech
Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for Medic...

Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for Medicaid Fierce Pharma
Trump Slaps 100% Tariffs on Some Drug Imports. What to Know. - Barron's

Trump Slaps 100% Tariffs on Some Drug Imports. What to Know. Barron's
Trump’s complete pharmaceutical tariff opens a critical opportunity for MFN and domestic manufact...

US starts engaging drugmakers on putting Trump’s MFN pricing into law - KFGO

US starts engaging drugmakers on putting Trump’s MFN pricing into law KFGO
Biopharma bites: PhRMA rebukes Trump's call to codify MFN, plus Pfizer's base editing deal and mo...

Biopharma bites: PhRMA rebukes Trump's call to codify MFN, plus Pfizer's base editing deal and more from Charles River FirstWord Pharma
U.S. seeking drugmakers’ views to codify MFN policy (LLY:NYSE) - Seeking Alpha

U.S. seeking drugmakers’ views to codify MFN policy (LLY:NYSE) Seeking Alpha
MFN wake-up call: platforms and energy under antitrust scrutiny - Ashurst

MFN wake-up call: platforms and energy under antitrust scrutiny Ashurst
From MFN to IRA, Experts Warn of a System Under Pressure in Wide-Ranging Policy Webinar - The Ame...

From MFN to IRA, Experts Warn of a System Under Pressure in Wide-Ranging Policy Webinar The American Journal of Managed Care® (AJMC®)
Senate Democrats Seeking Information on MFN Pharma Deals | PharmExec - Pharmaceutical Executive

Senate Democrats Seeking Information on MFN Pharma Deals | PharmExec Pharmaceutical Executive
U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact - Clinical Leader

U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact Clinical Leader
The Ongoing Impact of MFN Pricing - Pharmaceutical Executive

The Ongoing Impact of MFN Pricing Pharmaceutical Executive
J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts - Pharmaceutical T...

J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts Pharmaceutical Technology
Roche, Nvidia’s 'AI Factory'; Industry looks to soften MFN impact; Structure’s oral GLP-1 data; a...

Roche, Nvidia’s 'AI Factory'; Industry looks to soften MFN impact; Structure’s oral GLP-1 data; and more Endpoints News
WTO chief urges members to discuss core MFN rule as reform debate grows - Reuters

WTO chief urges members to discuss core MFN rule as reform debate grows Reuters
US starts engaging drugmakers on putting Trump's MFN pricing into law - Yahoo

US starts engaging drugmakers on putting Trump's MFN pricing into law Yahoo
Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals - Pharmaceutical Executive

Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals Pharmaceutical Executive
WTO Matters: Whither MFN – Its Relevance in a Rapidly Changing World - wita.org

WTO Matters: Whither MFN – Its Relevance in a Rapidly Changing World wita.org
AbbVie Reaches Agreement With Trump Administration, Joining MFN Initiatives - Pharmacy Times

AbbVie Reaches Agreement With Trump Administration, Joining MFN Initiatives Pharmacy Times
CMS extends deadline for MFN pricing pilot scheme - pharmaphorum

CMS extends deadline for MFN pricing pilot scheme pharmaphorum
US pharma MFN and tariff dynamics: What EU and UK leaders need to know - pharmaphorum

US pharma MFN and tariff dynamics: What EU and UK leaders need to know pharmaphorum
Walking a tightrope: Navigating US most-favored-nation prescription drug pricing in Canada | Glob...

Walking a tightrope: Navigating US most-favored-nation prescription drug pricing in Canada | Global law firm Norton Rose Fulbright
Drug Channels News Roundup, February 2026: Mark Cuban on FTC-ESI, What Patients Really Want, QALY...

Roundup: Every Most Favored Nation Agreement With the Trump Administration - Pharmacy Times

Roundup: Every Most Favored Nation Agreement With the Trump Administration Pharmacy Times
In brief SOTU remarks, Trump asks Congress to "codify" MFN - pharmaphorum

In brief SOTU remarks, Trump asks Congress to "codify" MFN pharmaphorum
J&J becomes latest pharma heavyweight to embrace MFN pricing - FirstWord Pharma

J&J becomes latest pharma heavyweight to embrace MFN pricing FirstWord Pharma
MFN - Not dead yet! - Hinrich Foundation

MFN - Not dead yet! Hinrich Foundation
MFN, Stopping Additional Insurer Subsidies, More Medicaid Fraud, and RSC Proposals - Paragon Heal...

MFN, Stopping Additional Insurer Subsidies, More Medicaid Fraud, and RSC Proposals Paragon Health Institute
Drug companies sign "Most Favored Nation" deals, then raise prices anyway - drugdiscoverytrends.com

Drug companies sign "Most Favored Nation" deals, then raise prices anyway drugdiscoverytrends.com
CMS Announces Voluntary Medicaid MFN Pricing Model - NAVLIN DAILY

CMS Announces Voluntary Medicaid MFN Pricing Model NAVLIN DAILY
Pharma’s Godfather moment: pulled back into tariff uncertainty - ING THINK economic and financial...

Pharma’s Godfather moment: pulled back into tariff uncertainty ING THINK economic and financial analysis | ING THINK
CMS Proposes MFN Drug Pricing Strategy for Mandatory GLOBE and GUARD Models | Jones Day - JD Supra

CMS Proposes MFN Drug Pricing Strategy for Mandatory GLOBE and GUARD Models | Jones Day JD Supra
Trump announces plan to impose 100% tariffs on imported drugs under MFN - mezha.net

Trump announces plan to impose 100% tariffs on imported drugs under MFN mezha.net
ViewPoints: A policy insider explains the risks MFN pricing poses to biotech - FirstWord Pharma

ViewPoints: A policy insider explains the risks MFN pricing poses to biotech FirstWord Pharma
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech - BioSpace

Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech BioSpace
Gifthealth delivers off-the-shelf solution to deliver MFN pricing - Health Tech World

Gifthealth delivers off-the-shelf solution to deliver MFN pricing Health Tech World
US comes up with two mandatory IRP use pricing models under Trump’s MFN strategy - Pharmaceutical...

US comes up with two mandatory IRP use pricing models under Trump’s MFN strategy Pharmaceutical Technology
J&J strikes MFN deal with Trump, reveals plan to build 2 US manufacturing sites - Fierce Pharma

J&J strikes MFN deal with Trump, reveals plan to build 2 US manufacturing sites Fierce Pharma
Is Waiting the Riskiest Drug Pricing Strategy? Why Scenario Planning Is the Smart First Move on M...

Is Waiting the Riskiest Drug Pricing Strategy? Why Scenario Planning Is the Smart First Move on MFN Syneos Health
Trump’s MFN drug pricing impact still unclear in Denmark and Sweden - Euractiv

Trump’s MFN drug pricing impact still unclear in Denmark and Sweden Euractiv
Transforming US drug access and production: MFN pricing deals and historic manufacturing investme...

Transforming US drug access and production: MFN pricing deals and historic manufacturing investments Pharmaceutical Technology
The Longer-Term Impact of MFN Pricing - Pharmaceutical Commerce

The Longer-Term Impact of MFN Pricing Pharmaceutical Commerce
Today at JPM: M&A simmers but no sparks, moving on from MFN, and gene therapy's MAHA moment - Fir...

Today at JPM: M&A simmers but no sparks, moving on from MFN, and gene therapy's MAHA moment FirstWord Pharma
Trump Calls on Congress To Codify Most Favored Nation Drug Pricing in SOTU - BioSpace

Trump Calls on Congress To Codify Most Favored Nation Drug Pricing in SOTU BioSpace
TrumpRx platform offers discounted prescription drugs - American Hospital Association

TrumpRx platform offers discounted prescription drugs American Hospital Association
9 pharma giants reach US drug price deals with Trump administration - Fierce Pharma

9 pharma giants reach US drug price deals with Trump administration Fierce Pharma
Today at JPM: Sanofi on MFN misfires, cautious IPO optimism, pharma's AI embrace, and more… - Fir...

Today at JPM: Sanofi on MFN misfires, cautious IPO optimism, pharma's AI embrace, and more… FirstWord Pharma
Several Drugmakers Expected to Announce MFN Deals with White House this Week - NAVLIN DAILY

Several Drugmakers Expected to Announce MFN Deals with White House this Week NAVLIN DAILY
Beyond Forecasts: Navigating MFN Uncertainty - Fierce Pharma

Beyond Forecasts: Navigating MFN Uncertainty Fierce Pharma
Trump Administration to Pursue Additional MFN Deals this Spring - NAVLIN DAILY

Trump Administration to Pursue Additional MFN Deals this Spring NAVLIN DAILY
Small, Mid-Cap Companies Plot European Expansion In The Age Of MFN - Citeline News & Insights

Small, Mid-Cap Companies Plot European Expansion In The Age Of MFN Citeline News & Insights
Pharma Companies Left Out of Trump Drug Pricing Deals Seek Path to Avoid Tariffs - Pharmaceutical...

Pharma Companies Left Out of Trump Drug Pricing Deals Seek Path to Avoid Tariffs Pharmaceutical Commerce
AbbVie, several other pharma companies near MFN deal with Trump, sources say - Reuters

AbbVie, several other pharma companies near MFN deal with Trump, sources say Reuters